Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance

Information intended for healthcare professionals only. This formulary decision guide was initiated, funded, and reviewed by Boehringer Ingelheim Limited and Lilly Diabetes Alliance. The format was developed by Guidelines in Practice. Prescribing information can be found on page 2 of the formulary decision guide.

Click here to download the formulary decision guide.

If the PDF does not load within 5 seconds, please refresh the page.

 

UK/TRJ/00705

Date of preparation: April 2018